Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jessica L. Dawson"'
Publikováno v:
Clinical Case Reports, Vol 12, Iss 4, Pp n/a-n/a (2024)
Key Clinical Message COVID‐19 infection may increase the likelihood of neutropenia in patients already on clozapine. In clozapine treated patients experiencing COVID‐19 associated neutropenia, adjunct therapy with lithium can be considered.
Externí odkaz:
https://doaj.org/article/e6d9f4a76ee74ab9927e5c97a3e0a60b
Autor:
Kenneth H. Wills, Stephen J. Behan, Michael J. Nance, Jessica L. Dawson, Thomas M. Polasek, Ashley M. Hopkins, Madelé van Dyk, Andrew Rowland
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 47 (2021)
Background: Clozapine is a key antipsychotic drug for treatment-resistant schizophrenia but exhibits highly variable pharmacokinetics and a propensity for serious adverse effects. Currently, these challenges are addressed using therapeutic drug monit
Externí odkaz:
https://doaj.org/article/e7aaeb1321764a4dab4ffd309d58ffe6
Publikováno v:
Journal of Clinical Psychopharmacology.
Background: Recent observational study evidence suggests that clozapine, unlike other antipsychotics, may be associated with a small increased risk of hematological malignancy. This study described characteristics of hematological and other cancers i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d9a84eb521c326ca47aeb5cda11a170
https://doi.org/10.1097/jcp.0000000000001699
https://doi.org/10.1097/jcp.0000000000001699
Publikováno v:
Journal of Clinical Psychopharmacology. 40:250-258
Purpose Clozapine-associated myocarditis (CAM) is a serious complication, mostly occurring in the first month of treatment. Public mental health in South Australia introduced a screening protocol in 2011 using baseline and weekly C-reactive protein a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b065aa18596794da8dba173fb1b1d8a
https://doi.org/10.1097/jcp.0000000000001193
https://doi.org/10.1097/jcp.0000000000001193
Autor:
Lisa R Wilton, Nicholas Procter, Scott R. Clark, Kim Y Chiew, Jessica L Dawson, J. Simon Bell
Publikováno v:
The Australian and New Zealand journal of psychiatry. 56(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfe409a498a96595cc1c42c56f52771d
https://pubmed.ncbi.nlm.nih.gov/34847749
https://pubmed.ncbi.nlm.nih.gov/34847749
Publikováno v:
The Lancet Psychiatry. 9:539-540
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3af0495cc9b1b0b13d881012a48917a
https://doi.org/10.1016/s2215-0366(22)00204-8
https://doi.org/10.1016/s2215-0366(22)00204-8
Publikováno v:
The lancet. Psychiatry. 9(5)
Clozapine is the most efficacious treatment for schizophrenia and is associated with lower overall mortality than are other antipsychotic drugs, despite the risk of agranulocytosis. Preliminary reports over the past 10 years suggest a possible risk o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::740458e03a8e22412fe72c165c93462a
https://pubmed.ncbi.nlm.nih.gov/35717957
https://pubmed.ncbi.nlm.nih.gov/35717957
Publikováno v:
The Australian and New Zealand journal of psychiatry. 56(1)
Objective: Concerns about intentional and unintentional poisoning present a barrier to wider use of clozapine in treatment-resistant schizophrenia. The objective of this study was to investigate decedent demographics and trends in fatal poisonings in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a757e86c4dc5068b3b0857a938edda
https://pubmed.ncbi.nlm.nih.gov/33736477
https://pubmed.ncbi.nlm.nih.gov/33736477
